Skip to main navigation
Skip to search
Skip to main content
Tel Aviv University Home
Update Request & User Guide (TAU staff only)
Link opens in a new tab
Search content at Tel Aviv University
Home
Experts
Research units
Research output
Datasets
Prizes
Activities
Press/Media
Use of Antipsychotics in the Treatment of Eating Disorders
Karen Borges
,
Yael Doreen Lewis
, Jessica Bentley
, Hubertus Himmerich
*
*
Corresponding author for this work
King's College London
Shalvata Mental Health Center
Research output
:
Chapter in Book/Report/Conference proceeding
›
Chapter
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Use of Antipsychotics in the Treatment of Eating Disorders'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Antipsychotics
100%
Eating Disorders
100%
Anorexia Nervosa
100%
Second-generation Antipsychotics
87%
Olanzapine
37%
Randomized Controlled Trial
25%
Binge Eating
25%
Bulimia Nervosa
25%
Aripiprazole
25%
Self-regulatory Systems
25%
Risperidone
12%
Haloperidol
12%
Weight Gain
12%
Sulpiride
12%
Placebo
12%
Serotonergic System
12%
Dopaminergic Neurotransmission
12%
Treatment Efficacy
12%
Treatment Group
12%
Reward System
12%
Between-group
12%
Placebo Groups
12%
DSM-5
12%
Psychopharmacological
12%
Case-controlled Study
12%
Eating Disorder Symptoms
12%
General Psychopathology
12%
Retrospective Case
12%
Adolescent Patients
12%
Statistical Manual of Mental Disorders
12%
Amisulpride
12%
Uncontrolled Study
12%
Quetiapine
12%
Pimozide
12%
Fifth Edition
12%
Homeostatic System
12%
ARFID
12%
Rumination Syndrome
12%
Pica Disorder
12%
Histaminergic Neurotransmission
12%
Medicine and Dentistry
Anorexia Nervosa
100%
Treatment of Eating Disorders
100%
Eating Disorder
37%
Olanzapine
37%
Placebo
25%
Randomized Controlled Trial
25%
Night Eating Syndrome
25%
Bulimia
25%
Aripiprazole
25%
Outpatient
12%
DSM-5
12%
Haloperidol
12%
Synaptic Transmission
12%
Food Intake
12%
Diagnostic and Statistical Manual of Mental Disorders
12%
Risperidone
12%
Levosulpiride
12%
Amisulpride
12%
Quetiapine
12%
Pimozide
12%
Rumination Syndrome
12%
Diseases
12%
Treatment Group
12%
Neurodevelopmental Disorder
12%
Neuroscience
Anorexia Nervosa
100%
Treatment of Eating Disorders
100%
Eating Disorder
37%
Olanzapine
37%
Placebo
25%
Randomized Controlled Trial
25%
Bulimia Nervosa
25%
Aripiprazole
25%
Binge Eating Disorder
25%
Risperidone
12%
Dopaminergic
12%
Synaptic Transmission
12%
Sulpiride
12%
Levosulpiride
12%
Serotonergic
12%
Diagnostic and Statistical Manual of Mental Disorders
12%
Amisulpride
12%
Reward System
12%
Quetiapine
12%
Pimozide
12%
Haloperidol
12%
Psychopathology
12%
Pharmacology, Toxicology and Pharmaceutical Science
Eating Disorder
100%
Anorexia Nervosa
100%
Olanzapine
37%
Placebo
25%
Randomized Controlled Trial
25%
Aripiprazole
25%
Bulimia
25%
Binge Eating Disorder
25%
Risperidone
12%
Dopamine Receptor Stimulating Agent
12%
4 (para chlorophenyl) 1 [3 (para fluorobenzoyl)propyl] 4 piperidinol
12%
Amisulpride
12%
Sulpiride
12%
Quetiapine
12%
Diagnostic and Statistical Manual of Mental Disorders
12%
DSM-5
12%
Pimozide
12%
Rumination Syndrome
12%
Diseases
12%
Treatment Group
12%
Mental Diseases
12%